Literature DB >> 977762

Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma.

A B Kay, A F Smith, C R McGavin, S B Tuft.   

Abstract

Levels of IgG, IgA, IgM, the total haemolytic complement (CH50), and the individual components C1q, C3, C4, C6, and C7 were measured in 29 pleural effusions. Of these, 18 were associated with carcinoma of the bronchus and 11 were non-malignant effusions including empyemas. The level of IgG was significantly lower in the malignant group when compared with non-malignant effusions. The usefulness of measurements of IgG with respect to malignant effusions associated with carcinoma of the bronchus requires an expanded study to show whether it has any real diagnostic value. There were no significant differences in other immunoglobulins, the CH50, and individual complement components between the two groups. The identification of total haemolytic activity in the majority of effusions in both groups indicates that all nine components of the classical pathway of complement, including macromolecules such as C1, can be present in pleural fluids.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977762      PMCID: PMC476207          DOI: 10.1136/jcp.29.10.887

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.

Authors:  T J PEKIN; N J ZVAIFLER
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

2.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

3.  Hypocomplementemia in rheumatoid arthritis.

Authors:  A E Franco; P H Schur
Journal:  Arthritis Rheum       Date:  1971 Mar-Apr

4.  Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  G G Hunder; F C McDuffie; N G Hepper
Journal:  Ann Intern Med       Date:  1972-03       Impact factor: 25.391

5.  Serum concentrations of G, A, and M immunoglobulins in patients with carcinoma, melanoma, and sarcoma.

Authors:  N R Hughes
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

6.  [Immune reactions during pleural effusions].

Authors:  A Hirsch; M Papiernik; M Saint-Paul; G Bonnaud; J Chretien
Journal:  Presse Med       Date:  1971-12-11       Impact factor: 1.228

7.  Albumin turnover in pleural effusions.

Authors:  W J Leckie; P Tothill
Journal:  Clin Sci       Date:  1965-10       Impact factor: 6.124

8.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

  8 in total
  3 in total

Review 1.  Potential biomarkers for lung cancer screening.

Authors:  Gabriella Sozzi; Mattia Boeri
Journal:  Transl Lung Cancer Res       Date:  2014-06

2.  Study of immunoglobulins in pleura and pleural effusions.

Authors:  L Telvi; F Jaubert; A Eyquem; J P Andreux; F Labrousse; J Chrétien
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

3.  Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

Authors:  Daniel Ajona; María J Pajares; Leticia Corrales; Jose L Perez-Gracia; Jackeline Agorreta; Maria D Lozano; Wenceslao Torre; Pierre P Massion; Juan P de-Torres; Eloisa Jantus-Lewintre; Carlos Camps; Javier J Zulueta; Luis M Montuenga; Ruben Pio
Journal:  J Natl Cancer Inst       Date:  2013-08-12       Impact factor: 13.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.